Evolve Private Wealth LLC bought a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 51,984 shares of the company’s stock, valued at approximately $6,724,000.
Several other institutional investors have also modified their holdings of MKGAF. Martin & Co. Inc. TN acquired a new stake in shares of Merck KGaA in the 2nd quarter worth about $2,054,000. WealthShield Partners LLC acquired a new stake in shares of Merck KGaA in the second quarter valued at approximately $320,000. W1M Asset Management Ltd bought a new stake in shares of Merck KGaA during the second quarter valued at approximately $1,412,000. Madison Wealth Partners Inc acquired a new position in shares of Merck KGaA during the second quarter worth approximately $1,031,000. Finally, Varma Mutual Pension Insurance Co acquired a new position in shares of Merck KGaA during the second quarter worth approximately $51,345,000. Institutional investors own 0.10% of the company’s stock.
Merck KGaA Stock Up 0.7%
MKGAF opened at $163.21 on Friday. Merck KGaA has a 12 month low of $116.68 and a 12 month high of $175.56. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The stock has a market cap of $21.09 billion, a P/E ratio of 24.92 and a beta of 0.96. The stock’s 50 day moving average price is $162.62 and its 200 day moving average price is $148.46.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
